4.5 Review

Nutritional factors in the prevention and management of coronary artery disease and heart failure

Journal

NUTRITION
Volume 31, Issue 2, Pages 283-291

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.nut.2014.08.011

Keywords

Nutrients; Polyunsaturated fatty acids; Vitamins; Pyridoxine; Lipoxins; Resolvins; Protectins; Heart failure; Atherosclerosis; Coronary artery disease; Nitric oxide; Asymmetrical dimethylarginine; Magnesium; Eicosanoids; Arrhythmias; Cytokines; L-arginine

Funding

  1. Ramalingaswami Fellowship of the Department of Biotechnology, New Delhi
  2. Department of Biotechnology (DBT) [BT/PR11627/MED/30/157/2010]
  3. Department of Science and Technology under Intensification of Research in High Priority Areas (IRPHA) [IR/SO/LU/03/2008/1]
  4. Defence Research and Development Organisation, New Delhi [TC/2519/INM-03/2011/CARS, INM-311]

Ask authors/readers for more resources

Nutritional factors such as magnesium, folic acid, vitamins B-12 and B-6, L-arginine, and polyunsaturated fatty acids (PUFAs) appear to be significantly beneficial for patients with coronary artery disease (CAD), and in the prevention and arresting the progression of HF and cardiac arrhythmias. Additionally, ingestion of adequate amounts of protein and maintaining normal concentrations of plasma albumin seem to be essential for these patients. These nutrients closely interact with the metabolism of L-arginine-nitric oxide (NO) system, essential fatty acids, and eicosanoids such that beneficial products such as NO, prostaglandin E-1, prostacyclin, prostaglandin I-3, lipoxins, resolvins, and protectins are generated and synthesis of proinflammatory cytokines is suppressed that results in platelet anti-aggregation, vasodilation, angiogenesis, and prevention of CAD, cardiac arrhythmias, and stabilization of HF. This implies that individuals at high risk for CAD, cardiac arrhythmias, and HF and those who have these diseases need to be screened for plasma levels of magnesium, folic acid, vitamins B-12 and B-6, L-arginine, NO, various PUFAs, lipoxin A(4), resolvins, protectins, asymmetrical dimethylarginine (an endogenous inhibitor of NO), albumin, and various eicosanoids and cytokines and correct their abnormalities to restore normal physiology. (C) 2015 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available